PT-141
Synthetic Melanocortin Receptor Agonist
You save $5.25 End of Summer Sale · through Aug 31 applied automatically at checkout — no code needed
Direct-source pricing: Solira works through manufacturing partnerships to reduce reseller markup while maintaining independent third-party testing and lot-specific COA verification.
Estimated delivery Fri, Aug 28 – Thu, Sep 3
Availability: In stock
The Solira Take
PT-141 (Bremelanotide) is a melanocortin-receptor agonist heptapeptide, derived as a metabolite of Melanotan II. Characterized in preclinical research on MC3R / MC4R signaling pathways.
Description
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide analogue of α-MSH. It differs from Melanotan II by the absence of a C-terminal amide. Supplied as lyophilized powder for laboratory research.
Supplied for in vitro research and preclinical investigation only. Independently verified by HPLC and mass spectrometry.
Product Specs
Research Applications
- Investigated in preclinical models for MC3R and MC4R selective activation.
- Studied in in vitro systems for central nervous system melanocortin signaling.
- Used in laboratory research examining cyclic peptide receptor affinity profiles.
- Evaluated in controlled preclinical settings for melanocortin receptor pharmacology.
Storage & Handling
Store sealed, dry, and protected from light.
Long-term storage: -20°C recommended.
Short-term storage: 2-8°C acceptable.
Reconstitution: Use sterile technique with bacteriostatic water.
Post-reconstitution: Stable up to 30 days at 2-8°C.
All handling instructions are intended for laboratory use only.
COA / Testing
Every batch of product sold by Solira undergoes independent third-party analytical testing to verify identity and purity, performed by Chromate.
- HPLC purity analysis — confirms compound purity
- Mass spectrometry — identity confirmation via molecular weight verification
- Lot-specific documentation — each COA corresponds to the specific manufacturing lot
COA available upon request. Contact us for lot-specific documentation.
This product is sold strictly as a research compound for in vitro laboratory use. It has not been evaluated or approved by the FDA for any human use. All products sold by Solira are for laboratory and research purposes only. Not for human consumption. Not for diagnostic or therapeutic use. Purchaser assumes all responsibility for the legal and proper use of this product.
